Gender differences in cardiovascular risk factors in incident diabetes

Women's Health Issues

Volumn 24, Issue 1, 2014, Pages

  Schroeder, Emily B ^a,b   Bayliss, Elizabeth A ^a,c   Daugherty, Stacie L ^a,b   Steiner, John F ^a,b  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INTEGRATED HEALTH CARE SYSTEM; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

ADULT; AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; DELIVERY OF HEALTH CARE, INTEGRATED; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; INSULIN; MALE; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS; SEX CHARACTERISTICS; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84892470438     PISSN: 10493867     EISSN: 18784321     Source Type: Journal    
DOI: 10.1016/j.whi.2013.09.008     Document Type: Article

References (31)

1. Adams A.S., Uratsu C., Dyer W., Magid D., O'Connor P., Beck A., et al. Health system factors and antihypertensive adherence in a racially and ethnically diverse cohort of new users. JAMA Internal Medicine 2013, 173:54-61.
2. Standards of medical care in diabetes-2012. Diabetes Care 2012, 35(Suppl. 1):S11-S63. American Diabetes Association (ADA).
3. Standards of medical care in diabetes-2013. Diabetes Care 2013, 36(Suppl. 1):S11-S66. American Diabetes Association.
4. Bayliss E.A., Blatchford P.J., Newcomer S.R., Steiner J.F., Fairclough D.L. The effect of incident cancer, depression and pulmonary disease exacerbations on type 2 diabetes control. Journal of General Internal Medicine 2011, 26:575-581.
5. Bertoni A.G., Clark J.M., Feeney P., Yanovski S.Z., Bantle J., Montgomery B., et al. Suboptimal control of glycemia, blood pressure, and LDL cholesterol in overweight adults with diabetes: the Look AHEAD Study. Journal of Diabetes and Its Complications 2008, 22:1-9.
6. Bird C.E., Fremont A.M., Bierman A.S., Wickstrom S., Shah M., Rector T., et al. Does quality of care for cardiovascular disease and diabetes differ by gender for enrollees in managed care plans?. Womens Health Issues 2007, 17:131-138.
7. Casagrande, S. S., Fradkin, J. E., Saydah, S. H., Rust, K. F., & Cowie, C. C. (2013). The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010. Diabetes Care, 36, 2271-2279.
8. Chou A.F., Brown A.F., Jensen R.E., Shih S., Pawlson G., Scholle S.H. Gender and racial disparities in the management of diabetes mellitus among Medicare patients. Womens Health Issues 2007, 17:150-161.
9. Cox E., Martin B.C., Van S.T., Garbe E., Siebert U., Johnson M.L. Good research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: The International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report-Part II. Value in Health 2009, 12:1053-1061.
10. Daugherty S.L., Masoudi F.A., Ellis J.L., Ho P.M., Schmittdiel J.A., Tavel H.M., et al. Age-dependent gender differences in hypertension management. Journal of Hypertension 2011, 29:1005-1011.
11. Elliott M.N., Fremont A., Morrison P.A., Pantoja P., Lurie N. A new method for estimating race/ethnicity and associated disparities where administrative records lack self-reported race/ethnicity. Health Services Research 2008, 43:1722-1736.
12. Ferrara A., Mangione C.M., Kim C., Marrero D.G., Curb D., Stevens M., et al. Sex disparities in control and treatment of modifiable cardiovascular disease risk factors among patients with diabetes: Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care 2008, 31:69-74.
13. Gregg E.W., Gu Q., Cheng Y.J., Narayan K.M., Cowie C.C. Mortality trends in men and women with diabetes, 1971 to 2000. Annals of Internal Medicine 2007, 147:149-155.
14. Holman R.R., Paul S.K., Bethel M.A., Matthews D.R., Neil H.A. 10-year follow-up of intensive glucose control in type 2 diabetes. New England Journal of Medicine 2008, 359:1577-1589.
15. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. American Journal of Public Health 1992, 82:703-710.
16. Larkin M.E., Backlund J.Y., Cleary P., Bayless M., Schaefer B., Canady J., et al. Disparity in management of diabetes and coronary heart disease risk factors by sex in DCCT/EDIC. Diabetic Medicine 2010, 27:451-458.
17. Montori V.M., Fernandez-Balsells M. Glycemic control in type 2 diabetes: time for an evidence-based about-face?. Annals of Internal Medicine 2009, 150:803-808.
18. Mosca L., Benjamin E.J., Berra K., Bezanson J.L., Dolor R.J., Lloyd-Jones D.M., et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: A guideline from the American Heart Association. Circulation 2011, 123:1243-1262.
19. Pilote L., Dasgupta K., Guru V., Humphries K.H., McGrath J., Norris C., et al. A comprehensive view of sex-specific issues related to cardiovascular disease. CMAJ 2007, 176:S1-44.
20. Pimenta E., Oparil S. Management of hypertension in the elderly. Nature Reviews Cardiology 2012, 9:286-296.
21. Quan H., Sundararajan V., Halfon P., Fong A., Burnand B., Luthi J.C., et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Medical Care 2005, 43:1130-1139.
22. Rose A.J., Berlowitz D.R., Manze M., Orner M.B., Kressin N.R. Comparing methods of measuring treatment intensification in hypertension care. Circulation Cardiovascular Quality Outcomes 2009, 2:385-391.
23. Schroeder E.B., Hanratty R., Beaty B.L., Bayliss E.A., Havranek E.P., Steiner J.F. Simultaneous control of diabetes, hypertension, and hyperlipidemia in two health systems. Circulation Cardiovascular Quality Outcomes 2012, 5:645-653.
24. Skyler J.S., Bergenstal R., Bonow R.O., Buse J., Deedwania P., Gale E.A., et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association. Journal of the American College of Cardiology 2009, 53:298-304.
25. Tobin M.D., Sheehan N.A., Scurrah K.J., Burton P.R. Adjusting for treatment effects in studies of quantitative traits: Antihypertensive therapy and systolic blood pressure. Statistics in Medicine 2005, 24:2911-2935.
26. Tseng C.L., Sambamoorthi U., Rajan M., Tiwari A., Frayne S., Findley P., et al. Are there gender differences in diabetes care among elderly Medicare enrolled veterans?. Journal of General Internal Medicine 2006, 21(Suppl. 3):S47-S53.
27. Vaccarino V., Parsons L., Every N.R., Barron H.V., Krumholz H.M. Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. New England Journal of Medicine 1999, 341:217-225.
28. Vaccarino V., Parsons L., Peterson E.D., Rogers W.J., Kiefe C.I., Canto J. Sex differences in mortality after acute myocardial infarction: changes from 1994 to 2006. Archives of Internal Medicine 2009, 169:1767-1774.
29. Wexler D.J., Grant R.W., Meigs J.B., Nathan D.M., Cagliero E. Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes Care 2005, 28:514-520.
30. Winston G.J., Barr R.G., Carrasquillo O., Bertoni A.G., Shea S. Sex and racial/ethnic differences in cardiovascular disease risk factor treatment and control among individuals with diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 2009, 32:1467-1469.
31. Zgibor J.C., Orchard T.J., Saul M., Piatt G., Ruppert K., Stewart A., et al. Developing and validating a diabetes database in a large health system. Diabetes Research and Clinical Practice 2007, 75:313-319.